Categories: AnalystsCleantech

Innergex Renewable has a 35 per cent upside, IA Securities says

With its recent solar project acquisition, Innergex Renewable Energy (TSX:INE) is expanding its footprint in Texas, says analyst Jeremy Rosenfield with Industrial Alliance Securities, who calls INE one of the most attractive investments in the renewable power sector.

On Monday, Longueuil, Quebec-based Innergex announced the acquisition and financial close of a 250MWAC/315MWDC greenfield solar project in Winkler County, West Texas, that comes with a 12-year power purchase agreement with Shell Energy North America, with the project expected to begin commercial operations during the third quarter of 2019.

CEO Michel Letellier says that the completion of the project, INE’s largest solar project to date, will demonstrate his company’s commitment to growing its portfolio of assets.

”With this acquisition, we are in a good position to provide peak renewable power to the ERCOT market, complementing wind energy production and diversifying our footprint in the state,” says Letellier in a statement. “This acquisition brings us closer to exceeding our goal of achieving net 2,000 MW by 2020 and we intend to continue pursuing development and acquisition opportunities of high-quality renewable energy assets to further generate value for our stakeholders.”

As Rosenfield reports, the company expects high single-digit/low double-digit equity returns from the project, which the analyst says is in an attractive market.

“INE’s long-term growth story remains among the most attractive investment options in the renewable power sector at this time,” says Rosenfield in a client update on Tuesday. “The Company continues to execute on recently-acquired development projects from the Alterra power acquisition, and the [Energia Llaima] Chilean renewable partnership.”

“We continue to like INE for its (1) low-risk long-term growth profile, (2) the longevity of its high-quality hydro portfolio, (3) strong expected FCF/share growth (7-9 per cent/year through 2022), (4) healthy dividend characteristics (~5 per cent yield, 8GW in Canada, France, the US, Iceland and Latin America),” he says.

The analyst predicts INE’s EBITDA in F2018 to be $404.5 million and in F2019 to be $400.0 million. In his update, Rosenfield reiterated his “Strong Buy” rating and $18.00 target price, representing a projected 12-month return of 35.3 per cent at the time of publication.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: ine
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

JUSH stock is a buy, Beacon says

With its first quarter results on deck, Beacon Securities analyst Russell Stanley thinks Jushi Holdings (Jushi Holdings Stock Quote, Chart,… [Read More]

9 hours ago

Is Curaleaf stock still a buy?

The stock has been a steady climber since last October, but ahead of earnings is Curaleaf (Curaleaf Stock Quote, Chart,… [Read More]

12 hours ago

OpenText price target cut at National Bank

Following third quarter results he describes as "in-line", National Bank Financial analyst Richard Tse has cut his price target on… [Read More]

13 hours ago

Silicon Motion stock still a buy, Roth says

Following the company's first quarter results, Roth MKM analyst Suji Desilava remains bullish on Silicon Motion Technology (Silicon Motion Technology… [Read More]

13 hours ago

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

3 days ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

4 days ago